1. Home
  2. CIVB vs VALN Comparison

CIVB vs VALN Comparison

Compare CIVB & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

HOLD

Current Price

$28.21

Market Cap

571.6M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$5.36

Market Cap

582.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CIVB
VALN
Founded
1884
2012
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
571.6M
582.2M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
CIVB
VALN
Price
$28.21
$5.36
Analyst Decision
Buy
Buy
Analyst Count
6
4
Target Price
★ $30.92
$12.25
AVG Volume (30 Days)
★ 103.5K
23.4K
Earning Date
10-22-2026
11-12-2026
Dividend Yield
★ 2.56%
N/A
EPS Growth
★ 31.34
N/A
EPS
★ 1.41
N/A
Revenue
★ $19,023,000.00
N/A
Revenue This Year
$10.45
N/A
Revenue Next Year
$4.72
$87.65
P/E Ratio
$19.91
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$21.10
$4.75
52 Week High
$29.97
$12.18

Technical Indicators

Market Signals
Indicator
CIVB
VALN
Relative Strength Index (RSI) 66.50 37.29
Support Level $27.97 $5.10
Resistance Level $29.31 $5.52
Average True Range (ATR) 0.57 0.21
MACD 0.19 -0.03
Stochastic Oscillator 83.07 5.70

Price Performance

Historical Comparison
CIVB
VALN

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: